Kenya National AIDS & STI Control Programme   Report issue

Government Phase 3 Phase 4
Founded: Nairobi Kenya (1987)

Organization Overview

First Clinical Trial
2015
NCT02390310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kenya National AIDS & STI Control Programme

Active Ingredients

Drugs in Phase 4 Trials (2)

doxycycline (vibramycin) (1 trial)

tenofovir (viread) (1 trial)

Drugs in Phase 3 Trials (2)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

Drugs in Other Trials (2)

lidocaine (xylocaine) (1 trial)

prilocaine (citanest) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 4)

Gonorrhea (Phase 4)

Infections (Phase 4)

Malaria (Phase 3)

Sexually Transmitted Diseases (Phase 4)

Syphilis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6